Analyst Ratings for Synta Pharma. (snta)
snta Rating Summary
snta Price Target Summary
- Highest: $22.00 (Jefferies)
- Lowest: $6.00 (ThinkEquity)
- Average: $11.86
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.86 (+57.9%)
Avg. $ Target:
$11.86 (+57.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2013 | BMO Capital | Downgrade | Market Perform (Outperform) |
9.00 (18.00) |
9.37 | 7.51 | -19.85% | Details |
| 4/2/2013 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
8.78 | 7.51 | -14.46% | Details |
| 12/13/2012 | Brean Capital | New Coverage | Buy (N/A) |
12.00 (N/A) |
8.61 | 7.51 | -12.78% | Details |
| 8/30/2012 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
6.92 | 7.51 | 8.53% | Details |
| 5/22/2012 | Jefferies » Updated 10/1/2012 |
New Coverage | Buy (N/A) |
22.00 (15.00) |
4.10 | 7.51 | 83.17% | Details |
| 1/5/2012 | Rodman & Renshaw | New Coverage | Market Outperform (N/A) |
8.00 (N/A) |
4.83 | 7.51 | 55.49% | Details |
| 11/8/2011 | ThinkEquity | New Coverage | Buy (N/A) |
6.00 (N/A) |
3.55 | 7.51 | 111.55% | Details |
| 2/28/2011 | Canaccord Genuity » Updated 2/23/2012 |
Upgrade | Buy (N/A) |
8.00 (N/A) |
5.69 | 7.51 | 31.99% | Details |
| 8/26/2010 | Morgan Joseph | New Coverage | Buy (N/A) |
N/A (N/A) |
2.82 | 7.51 | 166.31% | Details |
